Cargando…
Dysregulation of Protein S in COVID-19
Coronavirus Disease 2019 (COVID-19) has been widely associated with increased thrombotic risk, with many different proposed mechanisms. One such mechanism is acquired deficiency of protein S (PS), a plasma protein that regulates coagulation and inflammatory processes, including complement activation...
Autores principales: | Sim, Martha M.S., Wood, Jeremy P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395234/ https://www.ncbi.nlm.nih.gov/pubmed/36494145 http://dx.doi.org/10.1016/j.beha.2022.101376 |
Ejemplares similares
-
T-cell dysregulation in COVID-19
por: Kalfaoglu, Bahire, et al.
Publicado: (2021) -
COVID-19 disease and immune dysregulation
por: Davitt, Ethan, et al.
Publicado: (2022) -
Mechanism of COVID-19-Related Proteins in Spinal Tuberculosis: Immune Dysregulation
por: Chen, Liyi, et al.
Publicado: (2022) -
Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis
por: Sim, Martha M. S., et al.
Publicado: (2023) -
Dysregulation of immunity in COVID-19 and SLE
por: Hejazian, Seyyed Sina, et al.
Publicado: (2022)